We recently reported an association between oxidative stress-related gene variations and GDM risk, such as myeloperoxidase (MPO) G-463A (59), CYP2E1 C-1054T, and its combination with a 96-bp insertion/deletion (I/D) polymorphism (60). This evidence concerns the gene CYP2E1 and gestational diabetes.